Understanding bat immunity to viruses
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
['FUNDING_R21'] · COMMONWEALTH SCIENTIFIC & INDUST RES ORG · NIH-10618969
This study looks at how Australian black flying fox bats fight off dangerous viruses like Hendra and Nipah, with the goal of understanding their unique immune system to help prevent these viruses from spreading to humans and other animals.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COMMONWEALTH SCIENTIFIC & INDUST RES ORG (nih funded) |
| Locations | 1 site (VICTORIA, AUSTRALIA) |
| Trial ID | NIH-10618969 on ClinicalTrials.gov |
What this research studies
This research investigates how bats, particularly the Australian black flying fox, respond to viral infections, focusing on their unique immune mechanisms. The study aims to uncover the antiviral responses of bats to highly pathogenic viruses like Hendra and Nipah, which have high fatality rates in humans. By examining the immune responses of these bats, researchers hope to gain insights that could help predict and prevent virus spillover to humans and other animals. The methodology includes studying the expression of interferon alpha and other immune responses in bats following viral exposure.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk of zoonotic infections, particularly those in regions where bat-transmitted viruses are prevalent.
Not a fit: Patients who are not at risk of exposure to zoonotic viruses or who live in areas without bat populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing zoonotic virus transmission from bats to humans.
How similar studies have performed: While research on bat immunology is still developing, there have been promising findings regarding their unique immune responses, suggesting potential for breakthroughs in understanding viral infections.
Where this research is happening
VICTORIA, AUSTRALIA
- COMMONWEALTH SCIENTIFIC & INDUST RES ORG — VICTORIA, AUSTRALIA (ACTIVE)
Researchers
- Principal investigator: BAKER, MICHELLE L — COMMONWEALTH SCIENTIFIC & INDUST RES ORG
- Study coordinator: BAKER, MICHELLE L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.